(Q34655081)

3 August 2017

title

Evidence for induction of the ornithine transcarbamylase expression in Alzheimer's disease (English)

1 reference

3 August 2017

21

1 reference

ORCID Public Data File 2021

3 August 2017

1 reference

Jean-Jacques Hauw

13

object named as

Hauw JJ

1 reference

3 August 2017

Bensemain F

1

1 reference

3 August 2017

Hot D

2

1 reference

3 August 2017

Ferreira S

3

1 reference

3 August 2017

Dumont J

4

1 reference

3 August 2017

Bombois S

5

1 reference

3 August 2017

Maurage CA

6

1 reference

3 August 2017

Huot L

7

1 reference

3 August 2017

Hermant X

8

1 reference

3 August 2017

Levillain E

9

1 reference

3 August 2017

Hubans C

10

1 reference

3 August 2017

Hansmannel F

11

1 reference

3 August 2017

Chapuis J

12

1 reference

3 August 2017

Schraen S

14

1 reference

3 August 2017

Lemoine Y

15

1 reference

3 August 2017

Buée L

16

1 reference

3 August 2017

Berr C

17

1 reference

3 August 2017

Mann D

18

1 reference

3 August 2017

Pasquier F

19

1 reference

3 August 2017

Amouyel P

20

1 reference

3 August 2017

language of work or name

English

0 references

publication date

25 September 2007

1 reference

3 August 2017

1 reference

3 August 2017

volume

14

1 reference

3 August 2017

issue

1

1 reference

3 August 2017

page(s)

106-116

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.mp.4002089

3 August 2017

exact match

0 references

cites work

Contribution of APOE promoter polymorphisms to Alzheimer's disease risk

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002089

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002089

Blood ammonia and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002089

Hyperammonemia in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002089

Hyperammonemia and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002089

BRCA1 may modulate neuronal cell cycle re-entry in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002089

Molecular genetics of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002089

7 January 2021

Molecular genetics of late-onset Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002089

7 January 2021

Replication of linkage studies of complex traits: an examination of variation in location estimates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002089

7 January 2021

A gene expression profile of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002089

7 January 2021

High-throughput imaging of brain gene expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002089

7 January 2021

Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002089

7 January 2021

Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002089

7 January 2021

Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002089

7 January 2021

Genetic variability in the regulatory region of presenilin 1 associated with risk for Alzheimer's disease and variable expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002089

7 January 2021

Regulatory region variability in the human presenilin-2 (PSEN2) gene: potential contribution to the gene activity and risk for AD.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002089

7 January 2021

Characterization of two APP gene promoter polymorphisms that appear to influence risk of late-onset Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002089

7 January 2021

Relevance and limitations of public databases for microarray design: a critical approach to gene predictions.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002089

7 January 2021

Neuropathological stageing of Alzheimer-related changes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002089

7 January 2021

Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002089

7 January 2021

Nonoverlapping but synergetic tau and APP pathologies in sporadic Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002089

7 January 2021

A direct method for the estimation of ornithine carbamoyltransferase activity in serum

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002089

7 January 2021

An arginine to glutamine mutation in residue 109 of human ornithine transcarbamylase completely abolishes enzymatic activity in Cos1 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002089

7 January 2021

A Bayesian analysis of the minimum AIC procedure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002089

7 January 2021

Cox proportional hazards survival regression in haplotype-based association analysis using the Stochastic-EM algorithm.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002089

7 January 2021

Arginine metabolism and the synthesis of nitric oxide in the nervous system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002089

7 January 2021

Neurobiology of ammonia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002089

7 January 2021

L-Citrulline recycle for synthesis of NO in cerebral perivascular nerves and endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002089

7 January 2021

Arginine metabolic enzymes, nitric oxide and infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002089

7 January 2021

Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002089

7 January 2021

The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002089

7 January 2021

Ammonia and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002089

7 January 2021

Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002089

7 January 2021

Say NO to Alzheimer's disease: the putative links between nitric oxide and dementia of the Alzheimer's type

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002089

7 January 2021

Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002089

7 January 2021

Neurovascular mechanisms of Alzheimer's neurodegeneration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002089

7 January 2021

Divide and die: cell cycle events as triggers of nerve cell death.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4002089

7 January 2021

Identifiers

DOI

10.1038/SJ.MP.4002089

1 reference

Dimensions Publication ID

3 August 2017

1035923473

0 references

1 reference